Merck’s Welireg Gets Orphan Pricing Ahead Of Broader RCC Indications

Drug From $1.1bn Peloton Buy Boosts Renal Cancer Franchise

White Pills Spilling From A Medicine Bottle Forming A Dollar Sign
Merck priced Welireg at $26,400 per month, before discounts and rebates • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from New Products

More from Scrip